Related Experiment Video
Updated: May 3, 2026

Hollow Microneedle-based Sensor for Multiplexed Transdermal Electrochemical Sensing
Published on: June 1, 2012
Novel sensory surface for creatine kinase electrochemical detection
Felismina T C Moreira1, Rosa A F Dutra2, João P Noronha3
1BioMark/ISEP, Instituto Superior de Engenharia do Porto, Porto, Portugal; UOSE, INESC-Porto, Faculdade Ciências/Universidade Porto, Porto, Portugal; REQUIMTE/FCT-UNL, Faculdade de Ciências e Tecnologia da Universidade Nova de Lisboa, Portugal.
A novel biosensor immobilizes phosphorylated creatine on screen-printed electrodes for quantifying creatine kinase isoenzyme (CK-MB). This mediator-free biosensor offers high sensitivity and selectivity for cardiac biomarker detection.
Area of Science:
- Electrochemistry
- Biosensor Technology
- Biomarker Detection
Background:
- Creatine kinase isoenzyme (CK-MB) is a critical cardiac biomarker for ischemic conditions.
- Existing methods for CK-MB quantification can be complex and time-consuming.
- There is a need for rapid, sensitive, and selective point-of-care diagnostic tools.
Purpose of the Study:
- To develop a novel biosensor for quantifying CK-MB using immobilized phosphorylated creatine.
- To investigate the electrochemical properties and analytical performance of the developed biosensor.
- To evaluate the biosensor's applicability in biological fluids for point-of-care testing.
Main Methods:
- Immobilization of phosphorylated creatine onto aminated screen-printed electrodes via self-assembled monolayers.
- Electrochemical characterization using Electrochemical Impedance Spectroscopy (EIS) and Cyclic Voltammetry (CV).
- Quantification of CK-MB using Square Wave Voltammetry (SWV) in mediator-free conditions.
Main Results:
- The biosensor demonstrated a limit of detection of 0.11 µg/mL for CK-MB.
- High selectivity was observed against potential interfering substances like troponin T, BSA, and myoglobin.
- The biosensor showed good stability at room temperature and successful application in biological fluids.
Conclusions:
- A novel, mediator-free biosensor for CK-MB detection based on immobilized phosphorylated creatine has been successfully developed.
- The biosensor exhibits excellent sensitivity, selectivity, and stability, making it suitable for clinical applications.
- This technology holds significant promise for point-of-care diagnostic applications due to its low cost and small device size.

